M

MTNB

Matinas Biopharm

0.81

-0.05-5.63%
Pre Market: 0.8300  +0.0150  +1.84%09:09 06/02 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

0

1.10M

3.19M

33.33K

158.33K

Net Income

-24.25M

-22.94M

-21.00M

-23.28M

-22.45M

ROE

-1.8073

-0.8211

-0.4712

-0.4007

-0.4639

ROA

-1.285

-0.6562

-0.3956

-0.352

-0.4037

EPS

-4.9839

-5.2797

-4.8422

-5.6331

-5.9017

BVPS

1.492

4.4292

8.4314

12.136

15.9236

Asset Turnover

0

0.0313

0.0601

0.0005

0.0028

Debt-to-Asset

0.3996

0.2333

0.1826

0.144

0.102

Current Ratio

3.0101

5.9279

8.0569

11.726

17.2538

Quick Ratio

--

--

--

--

--